A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.


Updates from The Motley Fool

Latest updates on Meridian Bioscience from Fool.com.  The Fool has written over 100 articles on Meridian Bioscience.


Stock Performance

View Interactive VIVO Charts
Sponsored by

Key Data Points

Primary metrics and data points about Meridian Bioscience.
Current Price: $12.75
Prev Close: $12.75
Open: $12.80
Bid: $9.50
Ask: $12.95
Day's Range: $12.60 - $12.95
52wk Range: $10.75 - $21.49
Volume: 1,049,245
Avg Vol 568,924
Market Cap: $534M
P/E (ttm): 17.96
EPS (ttm): $0.71
Div & Yield: $0.00 (3.9%)

Company Rating

What our community thinks about Meridian Bioscience.
CAPS Rating 5 out of 5
 
459 Outperform
10 Underperform
CAPS All Stars
 
72 Outperform
2 Underperform

How do you think Meridian Bioscience will perform against the market?



You pick for Meridian Bioscience is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John A. Kraeutler, CEO

25% Approve

Based on 28 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Meridian Bioscience.

A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers